Compare · ELV vs MTAC
ELV vs MTAC
Side-by-side comparison of Elevance Health Inc. (ELV) and MedTech Acquisition Corporation (MTAC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and MTAC operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $90.33B, about 292.6x MTAC ($308.8M).
- ELV has hit the wire 3 times in the past 4 weeks while MTAC has been quiet.
- ELV has more recent analyst coverage (23 ratings vs 0 for MTAC).
- Company
- Elevance Health Inc.
- MedTech Acquisition Corporation
- Price
- -
- -
- Market cap
- $90.33B
- $308.8M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 3
- 0
- Recent ratings
- 23
- 0
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
MedTech Acquisition Corporation
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest ELV
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- EVP & Chief Legal Officer Wessling Erin M covered exercise/tax liability with 349 shares, decreasing direct ownership by 5% to 7,230 units (SEC Form 4)
- EVP & Chief HR Officer Craig Ryan R covered exercise/tax liability with 144 shares, decreasing direct ownership by 2% to 6,530 units (SEC Form 4)
- Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
- Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
Latest MTAC
- Szela Mary T was granted 84,899 shares, increasing direct ownership by 30% to 364,862 units (SEC Form 4)
- Marshak Richard was granted 14,752 shares, increasing direct ownership by 118% to 27,251 units (SEC Form 4)
- Cox Bryan F. was granted 14,752 shares, increasing direct ownership by 21% to 86,696 units (SEC Form 4)
- Stevens Jennifer was granted 14,752 shares, increasing direct ownership by 82% to 32,783 units (SEC Form 4)
- Devlin Jodi was granted 17,500 shares (SEC Form 4)
- Murphy Sean was granted 34,144 shares, increasing direct ownership by 205% to 50,788 units (SEC Form 4)
- Katz Steven C was granted 34,144 shares, increasing direct ownership by 99% to 68,587 units (SEC Form 4)
- SEC Form 4 filed by Murphy Sean
- SEC Form 4 filed by Marshak Richard
- SEC Form 424B3 filed by MedTech Acquisition Corporation